Fates of retroviral core components during unrestricted and TRIM5-restricted infection.

TRIM5 proteins can restrict retroviral infection soon after delivery of the viral core into the cytoplasm. However, the molecular mechanisms by which TRIM5α inhibits infection have been elusive, in part due to the difficulty of developing and executing biochemical assays that examine this stage of t...

Full description

Bibliographic Details
Main Authors: Sebla B Kutluay, David Perez-Caballero, Paul D Bieniasz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-03-01
Series:PLoS Pathogens
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505372/?tool=EBI
_version_ 1818700132749672448
author Sebla B Kutluay
David Perez-Caballero
Paul D Bieniasz
author_facet Sebla B Kutluay
David Perez-Caballero
Paul D Bieniasz
author_sort Sebla B Kutluay
collection DOAJ
description TRIM5 proteins can restrict retroviral infection soon after delivery of the viral core into the cytoplasm. However, the molecular mechanisms by which TRIM5α inhibits infection have been elusive, in part due to the difficulty of developing and executing biochemical assays that examine this stage of the retroviral life cycle. Prevailing models suggest that TRIM5α causes premature disassembly of retroviral capsids and/or degradation of capsids by proteasomes, but whether one of these events leads to the other is unclear. Furthermore, how TRIM5α affects the essential components of the viral core, other than capsid, is unknown. To address these questions, we devised a biochemical assay in which the fate of multiple components of retroviral cores during infection can be determined. We utilized cells that can be efficiently infected by VSV-G-pseudotyped retroviruses, and fractionated the cytosolic proteins on linear gradients following synchronized infection. The fates of capsid and integrase proteins, as well as viral genomic RNA and reverse transcription products were then monitored. We found that components of MLV and HIV-1 cores formed a large complex under non-restrictive conditions. In contrast, when MLV infection was restricted by human TRIM5α, the integrase protein and reverse transcription products were lost from infected cells, while capsid and viral RNA were both solubilized. Similarly, when HIV-1 infection was restricted by rhesus TRIM5α or owl monkey TRIMCyp, the integrase protein and reverse transcription products were lost. However, viral RNA was also lost, and high levels of preexisting soluble CA prevented the determination of whether CA was solubilized. Notably, proteasome inhibition blocked all of the aforementioned biochemical consequences of TRIM5α-mediated restriction but had no effect on its antiviral potency. Together, our results show how TRIM5α affects various retroviral core components and indicate that proteasomes are required for TRIM5α-induced core disruption but not for TRIM5α-induced restriction.
first_indexed 2024-12-17T15:00:05Z
format Article
id doaj.art-273780abbffe4f918789c7230f890c8b
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-17T15:00:05Z
publishDate 2013-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-273780abbffe4f918789c7230f890c8b2022-12-21T21:43:56ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742013-03-0193e100321410.1371/journal.ppat.1003214Fates of retroviral core components during unrestricted and TRIM5-restricted infection.Sebla B KutluayDavid Perez-CaballeroPaul D BieniaszTRIM5 proteins can restrict retroviral infection soon after delivery of the viral core into the cytoplasm. However, the molecular mechanisms by which TRIM5α inhibits infection have been elusive, in part due to the difficulty of developing and executing biochemical assays that examine this stage of the retroviral life cycle. Prevailing models suggest that TRIM5α causes premature disassembly of retroviral capsids and/or degradation of capsids by proteasomes, but whether one of these events leads to the other is unclear. Furthermore, how TRIM5α affects the essential components of the viral core, other than capsid, is unknown. To address these questions, we devised a biochemical assay in which the fate of multiple components of retroviral cores during infection can be determined. We utilized cells that can be efficiently infected by VSV-G-pseudotyped retroviruses, and fractionated the cytosolic proteins on linear gradients following synchronized infection. The fates of capsid and integrase proteins, as well as viral genomic RNA and reverse transcription products were then monitored. We found that components of MLV and HIV-1 cores formed a large complex under non-restrictive conditions. In contrast, when MLV infection was restricted by human TRIM5α, the integrase protein and reverse transcription products were lost from infected cells, while capsid and viral RNA were both solubilized. Similarly, when HIV-1 infection was restricted by rhesus TRIM5α or owl monkey TRIMCyp, the integrase protein and reverse transcription products were lost. However, viral RNA was also lost, and high levels of preexisting soluble CA prevented the determination of whether CA was solubilized. Notably, proteasome inhibition blocked all of the aforementioned biochemical consequences of TRIM5α-mediated restriction but had no effect on its antiviral potency. Together, our results show how TRIM5α affects various retroviral core components and indicate that proteasomes are required for TRIM5α-induced core disruption but not for TRIM5α-induced restriction.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505372/?tool=EBI
spellingShingle Sebla B Kutluay
David Perez-Caballero
Paul D Bieniasz
Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
PLoS Pathogens
title Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
title_full Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
title_fullStr Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
title_full_unstemmed Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
title_short Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
title_sort fates of retroviral core components during unrestricted and trim5 restricted infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505372/?tool=EBI
work_keys_str_mv AT seblabkutluay fatesofretroviralcorecomponentsduringunrestrictedandtrim5restrictedinfection
AT davidperezcaballero fatesofretroviralcorecomponentsduringunrestrictedandtrim5restrictedinfection
AT pauldbieniasz fatesofretroviralcorecomponentsduringunrestrictedandtrim5restrictedinfection